Skip to main content
logo
Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.3115
-0.0105 (-3.26%)
At close: Aug 1, 2025, 4:00 PM
0.3100
-0.0015 (-0.48%)
After-hours: Aug 1, 2025, 7:31 PM EDT

Carisma Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
19.9619.6314.929.83--
Revenue Growth (YoY)
32.45%31.59%51.71%---
Cost of Revenue
51.3759.6774.1356.6234.39-
Gross Profit
-31.4-40.04-59.21-46.78-34.39-
Selling, General & Admin
18.620.1429.539.386.415.09
Research & Development
-----23.29
Operating Expenses
18.620.1429.539.386.4128.38
Operating Income
-50-60.18-88.73-56.16-40.79-28.38
Interest Expense
----3.15--
Interest & Investment Income
1.241.71.94-0.010.03
Other Non Operating Income (Expenses)
---0.08-1.92--
EBT Excluding Unusual Items
-48.77-58.48-86.88-61.23-40.78-28.35
Merger & Restructuring Charges
-2-2----
Pretax Income
-50.77-60.48-86.88-61.23-40.78-28.35
Net Income
-50.77-60.48-86.88-61.23-40.78-28.35
Net Income to Common
-50.77-60.48-86.88-61.23-40.78-28.35
Shares Outstanding (Basic)
424134211
Shares Outstanding (Diluted)
424134211
Shares Change (YoY)
2.71%23.66%1475.33%96.30%1.95%-
EPS (Basic)
-1.22-1.46-2.59-28.77-37.62-26.66
EPS (Diluted)
-1.22-1.46-2.59-28.77-37.62-26.66
Free Cash Flow
-47.67-60.04-82.31-9.78-39.2-27.45
Free Cash Flow Per Share
-1.14-1.45-2.46-4.59-36.16-25.82
Gross Margin
-157.30%-203.96%----
Operating Margin
-250.47%-306.54%-594.75%-571.10%--
Profit Margin
-254.28%-308.05%-582.34%-622.60%--
Free Cash Flow Margin
-238.75%-305.83%-551.71%-99.41%--
EBITDA
-47.68-56.83-85.89-54.27-40.11-27.93
EBITDA Margin
-238.84%-289.45%----
D&A For EBITDA
2.323.352.841.890.680.45
EBIT
-50-60.18-88.73-56.16-40.79-28.38
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q